October 8, 2024

Human Nutrition Market Size To Cross USD 719.69 Bn By 2032

The global human nutrition market size accounted for US$ 383.4 Bn in 2022 and is projected to reach around USD 719.69 Bn by 2032, growing at a CAGR of 6.50% from 2023 to 2032.

Human Nutrition Market Size 2023 To 2032

Report Summary

The global human nutrition market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the human nutrition market across the globe.

A comprehensive estimate on the human nutrition market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of human nutrition during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2989

Human Nutrition Market Report Scope

Report CoverageDetails
Market Size in 2023USD 408.32 Billion
Market Size by 2032USD 719.69 Billion
Growth Rate from 2023 to 2032CAGR of 6.50%
Largest MarketNorth America
Fastest Growth MarketAsia Pacific
Base Year2022
Forecast Period2023 To 2032
Segments CoveredBy Type, By Distribution Channel, and By Application
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized human nutrition market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Content Analytics Market Size To Cross USD 45.84 Bn By 2032

Human Nutrition Market Players

The report includes the profiles of key human nutrition market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • Hansen Holding A/S
  • USANA Health Science, Inc.
  • Pharmavite LLC.
  • Nestle S.A.
  • Kerry Group PLC
  • Glanbia PLC.
  • Corbion N.V.
  • ADM
  • Bayer Health Care AG
  • Amway Corp.

Market Segmentation

By Type

  • Vitamins
  • Proteins & Amino Acids
  • Probiotics
  • Fats & Fatty Acids
  • Carbohydrates
  • Minerals
  • Others

By Distribution Channel

  • OTC
  • Prescribed

By Application

  • Functional nutrients
  • Dietary supplements
  • Medical nutrition
  • Infant nutrition
  • Food & beverages

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Human Nutrition Market 

5.1. COVID-19 Landscape: Human Nutrition Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Human Nutrition Market, By Type

8.1. Human Nutrition Market Revenue and Volume, by Type, 2023-2032

8.1.1 Vitamins

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Proteins & Amino Acids

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Probiotics

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. Fats & Fatty Acids

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

8.1.5. Carbohydrates

8.1.5.1. Market Revenue and Volume Forecast (2020-2032)

8.1.6. Minerals

8.1.6.1. Market Revenue and Volume Forecast (2020-2032)

8.1.7. Others

8.1.7.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Human Nutrition Market, By Distribution Channel

9.1. Human Nutrition Market Revenue and Volume, by Distribution Channel, 2023-2032

9.1.1. OTC

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Prescribed

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Human Nutrition Market, By Application 

10.1. Human Nutrition Market Revenue and Volume, by Application, 2023-2032

10.1.1. Functional nutrients

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Dietary supplements

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Medical nutrition

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

10.1.4. Infant nutrition

10.1.4.1. Market Revenue and Volume Forecast (2020-2032)

10.1.5. Food & beverages

10.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Human Nutrition Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.1.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.1.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.1.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.1.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.1.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.1.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.2.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.2.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.2.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.2.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.7.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.2.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.3.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.3.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.3.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.3.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.7.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.3.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.4.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.4.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.4.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.7.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.4.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.5.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.5.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.5.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

11.5.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

Chapter 12. Company Profiles

12.1. Hansen Holding A/S

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. USANA Health Science, Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Pharmavite LLC.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Nestle S.A.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Kerry Group PLC

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Glanbia PLC.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Corbion N.V.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. ADM

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Bayer Health Care AG

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Amway Corp.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com